{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cutaneous&page=33",
    "query": {
      "condition": "Cutaneous",
      "page": 33
    },
    "page_size": 10
  },
  "pagination": {
    "page": 33,
    "page_size": 10,
    "total_count": 1581,
    "total_pages": 159,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cutaneous&page=34&page_size=10",
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cutaneous&page=32&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-11-13T08:52:26.835Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT04511013",
      "title": "A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Acral Lentiginous Melanoma",
        "Clinical Stage IV Cutaneous Melanoma AJCC v8",
        "Metastatic Cutaneous Melanoma",
        "Metastatic Malignant Neoplasm in the Brain",
        "Metastatic Melanoma",
        "Metastatic Mucosal Melanoma",
        "Pathologic Stage IV Cutaneous Melanoma AJCC v8"
      ],
      "interventions": [
        {
          "name": "Binimetinib",
          "type": "DRUG"
        },
        {
          "name": "Encorafenib",
          "type": "DRUG"
        },
        {
          "name": "Ipilimumab",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Nivolumab",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "DRUG",
        "BIOLOGICAL"
      ],
      "sponsor": "SWOG Cancer Research Network",
      "sponsor_class": "NETWORK",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 112,
      "start_date": "2021-01-06",
      "completion_date": "2027-06-30",
      "has_results": false,
      "last_update_posted_date": "2026-09-15",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 331,
      "location_summary": "Birmingham, Alabama • Fairhope, Alabama • Mobile, Alabama + 234 more",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        },
        {
          "city": "Fairhope",
          "state": "Alabama"
        },
        {
          "city": "Mobile",
          "state": "Alabama"
        },
        {
          "city": "Anchorage",
          "state": "Alaska"
        },
        {
          "city": "Anchorage",
          "state": "Alaska"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04511013"
    },
    {
      "nct_id": "NCT01964859",
      "title": "Feasibility Study for Fibroblast Autologous Skin Grafts",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Wounds and Injuries"
      ],
      "interventions": [
        {
          "name": "autologous skin fibroblasts",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Filler Product",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Johns Hopkins University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "65 Years",
        "sex": "ALL",
        "summary": "18 Years to 65 Years"
      },
      "enrollment_count": 80,
      "start_date": "2015-01-07",
      "completion_date": "2028-11-01",
      "has_results": false,
      "last_update_posted_date": "2026-06-09",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 1,
      "location_summary": "Baltimore, Maryland",
      "locations": [
        {
          "city": "Baltimore",
          "state": "Maryland"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01964859"
    },
    {
      "nct_id": "NCT04743362",
      "title": "A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions",
      "overall_status": "RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Skin Lesion",
        "Mucosal Lesion"
      ],
      "interventions": [
        {
          "name": "Dermoscopic imaging",
          "type": "DIAGNOSTIC_TEST"
        },
        {
          "name": "3-dimensional total body photography",
          "type": "DIAGNOSTIC_TEST"
        },
        {
          "name": "Confocal microscopy",
          "type": "DIAGNOSTIC_TEST"
        },
        {
          "name": "Optical Coherence Tomography imaging",
          "type": "DIAGNOSTIC_TEST"
        },
        {
          "name": "Ultrasound",
          "type": "DIAGNOSTIC_TEST"
        },
        {
          "name": "Hyperspectral imaging",
          "type": "DIAGNOSTIC_TEST"
        },
        {
          "name": "Electrical impedance spectroscopy",
          "type": "DIAGNOSTIC_TEST"
        },
        {
          "name": "Patient self-imaging",
          "type": "DIAGNOSTIC_TEST"
        }
      ],
      "intervention_types": [
        "DIAGNOSTIC_TEST"
      ],
      "sponsor": "Memorial Sloan Kettering Cancer Center",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": null,
        "sex": "ALL",
        "summary": "Not listed"
      },
      "enrollment_count": 5010,
      "start_date": "2021-02-02",
      "completion_date": "2031-08-02",
      "has_results": false,
      "last_update_posted_date": "2026-04-23",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 1,
      "location_summary": "New York, New York",
      "locations": [
        {
          "city": "New York",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04743362"
    },
    {
      "nct_id": "NCT00374335",
      "title": "Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Hemangioma"
      ],
      "interventions": [
        {
          "name": "abdominal ultrasound",
          "type": "PROCEDURE"
        },
        {
          "name": "Dermatologic Examination",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "PROCEDURE",
        "OTHER"
      ],
      "sponsor": "Children's Mercy Hospital Kansas City",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": "6 Months",
        "sex": "ALL",
        "summary": "Up to 6 Months"
      },
      "enrollment_count": 261,
      "start_date": "2006-09",
      "completion_date": "2009-12",
      "has_results": true,
      "last_update_posted_date": "2011-09-16",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 1,
      "location_summary": "Kansas City, Missouri",
      "locations": [
        {
          "city": "Kansas City",
          "state": "Missouri"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00374335"
    },
    {
      "nct_id": "NCT03259620",
      "title": "A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "conditions": [
        "Cutaneous Common Warts"
      ],
      "interventions": [
        {
          "name": "CLS006",
          "type": "DRUG"
        },
        {
          "name": "CLS006 Vehicle",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Maruho Co., Ltd.",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "2 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "2 Years and older"
      },
      "enrollment_count": 491,
      "start_date": "2017-10-30",
      "completion_date": "2018-11-07",
      "has_results": true,
      "last_update_posted_date": "2023-09-14",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 35,
      "location_summary": "Hot Springs, Arkansas • Oceanside, California • San Diego, California + 30 more",
      "locations": [
        {
          "city": "Hot Springs",
          "state": "Arkansas"
        },
        {
          "city": "Oceanside",
          "state": "California"
        },
        {
          "city": "San Diego",
          "state": "California"
        },
        {
          "city": "San Diego",
          "state": "California"
        },
        {
          "city": "Denver",
          "state": "Colorado"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03259620"
    },
    {
      "nct_id": "NCT06512259",
      "title": "AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction",
      "overall_status": "RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy"
      ],
      "interventions": [
        {
          "name": "AlloMend® Acellular Dermal Matrix allograft",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "AlloSource",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "FEMALE",
        "summary": "18 Years and older · Female only"
      },
      "enrollment_count": 200,
      "start_date": "2023-10-19",
      "completion_date": "2026-12-31",
      "has_results": false,
      "last_update_posted_date": "2025-11-21",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 1,
      "location_summary": "Joliet, Illinois",
      "locations": [
        {
          "city": "Joliet",
          "state": "Illinois"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06512259"
    },
    {
      "nct_id": "NCT00002226",
      "title": "Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Sarcoma, Kaposi",
        "HIV Infections"
      ],
      "interventions": [
        {
          "name": "SU5416",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "SUGEN",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 30,
      "start_date": null,
      "completion_date": null,
      "has_results": false,
      "last_update_posted_date": "2005-06-24",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 4,
      "location_summary": "Los Angeles, California • San Francisco, California • New York, New York",
      "locations": [
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "San Francisco",
          "state": "California"
        },
        {
          "city": "New York",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00002226"
    },
    {
      "nct_id": "NCT00563290",
      "title": "Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Recurrent Skin Cancer",
        "Squamous Cell Carcinoma of the Skin",
        "Stage 0 Chronic Lymphocytic Leukemia",
        "Stage I Chronic Lymphocytic Leukemia"
      ],
      "interventions": [
        {
          "name": "dasatinib",
          "type": "DRUG"
        },
        {
          "name": "laboratory biomarker analysis",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DRUG",
        "OTHER"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "sponsor_class": "NIH",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 7,
      "start_date": "2007-11",
      "completion_date": "2014-10",
      "has_results": true,
      "last_update_posted_date": "2015-06-18",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 3,
      "location_summary": "Cincinnati, Ohio • Columbus, Ohio • Houston, Texas",
      "locations": [
        {
          "city": "Cincinnati",
          "state": "Ohio"
        },
        {
          "city": "Columbus",
          "state": "Ohio"
        },
        {
          "city": "Houston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00563290"
    },
    {
      "nct_id": "NCT06202274",
      "title": "Clinical Study to Evaluate the Safety and Efficacy of Candela Technology",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Hair Reduction",
        "Tattoo Removal",
        "Wrinkle",
        "Acne",
        "Scars",
        "Benign Cutaneous Vascular Lesions",
        "Skin Conditions"
      ],
      "interventions": [
        {
          "name": "Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DEVICE"
      ],
      "sponsor": "Candela Corporation",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 500,
      "start_date": "2023-10-04",
      "completion_date": "2029-10-04",
      "has_results": false,
      "last_update_posted_date": "2026-11-02",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 2,
      "location_summary": "Jacksonville, Florida • Marlborough, Massachusetts",
      "locations": [
        {
          "city": "Jacksonville",
          "state": "Florida"
        },
        {
          "city": "Marlborough",
          "state": "Massachusetts"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06202274"
    },
    {
      "nct_id": "NCT02228889",
      "title": "RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Hernia, Ventral",
        "Intestinal Fistula",
        "Fibromatosis, Abdominal"
      ],
      "interventions": [
        {
          "name": "Abdominal wall reconstruction with Strattice",
          "type": "PROCEDURE"
        },
        {
          "name": "Assess pain intensity at last office visit preoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess pain interference at last office visit preoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess physical functioning at last office visit preoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess patient quality of life at last office visit preoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess patient pain intensity postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess pain interference postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess physical functioning postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess quality of life postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess hernia recurrence at 30 days postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess bulge at 30 days postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess Surgical Site Occurrences at 30 days postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess hernia recurrence at 1 year postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess bulge at 1 year postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess Surgical Site Occurrences at 1 year postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess overall complications at 30 days postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Assess overall complications at 1 year postoperatively",
          "type": "OTHER"
        },
        {
          "name": "Abdominal wall reconstruction with XenMatrix",
          "type": "PROCEDURE"
        },
        {
          "name": "Strattice",
          "type": "DEVICE"
        },
        {
          "name": "XenMatrix",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "PROCEDURE",
        "OTHER",
        "DEVICE"
      ],
      "sponsor": "Jeffrey Janis",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "99 Years",
        "sex": "ALL",
        "summary": "18 Years to 99 Years"
      },
      "enrollment_count": 46,
      "start_date": "2015-01",
      "completion_date": "2025-03-27",
      "has_results": true,
      "last_update_posted_date": "2025-06-06",
      "last_synced_at": "2026-11-13T08:52:26.835Z",
      "location_count": 1,
      "location_summary": "Columbus, Ohio",
      "locations": [
        {
          "city": "Columbus",
          "state": "Ohio"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02228889"
    }
  ]
}